Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
Open Access
- 3 October 2016
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 36 (12), 1707-1720
- https://doi.org/10.1038/onc.2016.337
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.2015
- MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancerCancer Letters, 2014
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer CellsCancer Cell, 2013
- Class IIa HDACs repressive activities on MEF2‐depedent transcription are associated with poor prognosis of ER + breast tumorsThe FASEB Journal, 2012
- HDAC1 regulates pluripotency and lineage specific transcriptional networks in embryonic and trophoblast stem cellsNucleic Acids Research, 2011
- The Emerging Role of EpCAM in Cancer and Stem Cell SignalingCancer Research, 2009
- Mammosphere‐derived gene set predicts outcome in patients with ER‐positive breast cancerThe Journal of Pathology, 2009
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic CarcinomaPancreas, 2008
- Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head groupInternational Journal of Cancer, 2007
- Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell PropertiesCancer Research, 2005